aspect of
drug)
→
ReceivesAction
→
shown in figure
| Typicality: | 0.328 |
| Saliency: | 0.373 |
| during clinical trials | 3 | temporal |
| effect → be shown in → figure | 17 |
| effect → be → shown | 10 |
| negative | neutral | positive |
| 0.217 | 0.715 | 0.068 |
| Raw frequency | 27 |
| Normalized frequency | 0.373 |
| Modifier score | 0.250 |
| Perplexity | 106.199 |